Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study

European Journal of Clinical Pharmacology

Volumn 60, Issue 6, 2004, Pages 439-444

  Carvajal, Alfonso ^a   Martín Arias, Luis H ^a   Vega, Eva ^a   García Sánchez, José Antonio ^a   Martín Rodríguez, Igor ^a   García Ortega, Pilar ^a   García Del Pozo, Javier ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Drug utilization study; Gastroprotection; NSAIDs

Indexed keywords

ACECLOFENAC; ACEXAMATE ZINC; ALMAGATE; ALUMINUM GLYCINATE; ALUMINUM HYDROXIDE; ANTACID AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; CORTICOSTEROID; DICLOFENAC; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; LANSOPRAZOLE; MAGALDRATE; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ADOLESCENT; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG USE; FEMALE; GENERAL PRACTITIONER; HEADACHE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SPAIN; STOMACH PROTECTION; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DATA COLLECTION; DRUG UTILIZATION; ENZYME INHIBITORS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; PROSPECTIVE STUDIES; PROTON PUMPS; QUESTIONNAIRES; SPAIN; STOMACH ULCER;

EID: 4544355527     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0782-8     Document Type: Article

References (19)

1. Burrull M, Madridejos R, Gregori A, Busquets E (1996) Antiinflamatorios no esteroideos y protección gastrointestinal: ¿prescripción adecuada en atención primaria? Aten Primaria 18:507-510
2. Erviti J (1999) Estudio multicéntrico prescripción- indicación de antiácidos y antiulcerosos en atención primaria. Aten Primaria 24:134-139
3. Lelorier J (1995) Patterns of prescription of nonsteroidal anti-inflammatory drugs and gastroprotective agents. J Rheumatol 43[Suppl]:26-27
4. Kephart G, Sketris I, Smith M, Maheu A, Brown M (1995) Coprescribing of nonsteroidal anti-inflammatory drugs and cytoprotective and antiulcer drugs in Nova Scotia's senior population. Clin Ther 17:1159-1173
5. Pathmakanthan S, O'Donovan DG, Sheehan KM, Murray FE (1998) Prospective evaluation of the utilization of aspirin and non-steroidal anti-inflammatory drugs in acute medical admissions. Ir Med J 91:58-60
6. Clinard F, Bardou M, Sgro C, Lefevre N, Raphael F, Paille F (2001) Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France. Eur J Clin Pharmacol 57:737-743
7. Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D (2002) Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. J Rheumatol 29:467-473
8. Sánchez JI, Larrabe J, Oscar J, Ojer D, Ruíz R, Bilbao J, Sologuren A (1997) Prescripción de antiinflamatorios no esteroides y gastroprotectores. Adecuación a criterios de calidad en atención primaria. Aten Primaria 20:127-132
9. Rodriguez de la Serna A (1998) Diferencias de toxicidad gastrointestinal de los distintos tipos de AINE. Gastroenterol 21[Suppl]:42-47
10. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888-1899
11. Cerezo Galán A, Díez del Pino A, Simó RM, Flores J, Freire C, Gallart MJ, Martínez Tutor MJ, Ribas i Sala J, Rodilla F, Vacas JS (1996) Estudio multicéntrico prescripción-indicación de antiácidos y antiulcerosos. Farm Hosp 20:91-103
12. Lanza FL (1998) A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 93:2037-2046
13. Jimenez MC, Castillo Ferrando JR, Torelló J, Merino N, Máiquez P, García Heras J (1998) Appropriateness of antiulcer drugs prescribing in primary care in Andalucía. Methods Find Exp Clin Pharmacol 20[Suppl]:82
14. Carvajal A, García del Pozo J, Del Olmo L, Rueda AM, Alvarez Requejo A (1999) Consumo de fármacos antiulcerosos en España. Aten Primaria 23:218-221
15. Morales Serna JC, Ignacio Garcia JM, Moreno Brea R, Alguacil Herrero MD (1997) Estudio de utilizaciõn de antiulcerosos e hipolipemiantes en el Distrito de Atención Primaria de Jerez (Cádiz). Aten Primaria 20:462-467
16. Rostom A, Wells G, Tugwell P, Welch V, Dubi C, McGowan J (2000) The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials. J Rheumatol 27:2203-2214
17. Castillo JR, Torello J, Hernandez A (2000) Liver injury caused by ebrotidine: a new example of the utility of the postmarketing surveillance. Eur J Clin Pharmacol 56:187-189
18. Fisher AA, Le Couteur DG (2001) Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. Drug Saf 24:39-57
19. Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JC, Descotes J (1991) Side effects of ranitidine. Drug Saf 6:94-117